The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Predictors of New-Onset Kidney Disease in a Community-Based Population
Abstract
Context Kidney disease is associated with an increased risk for the development of cardiovascular disease and end-stage renal disease; however, risk factors for kidney disease have not been well studied. Objective To identify predictors of the development of new-onset kidney disease. Design, setting, and participants A community-based, longitudinal cohort study of 2585 participants who attended both a baseline examination in 1978-1982 and a follow-up examination in 1998-2001, and who were free of kidney disease at baseline. Main outcome measures Kidney disease was assessed by the Modification of Diet in Renal Disease Study equation and defined by a glomerular filtration rate (GFR) in the fifth or lower percentile ( Results At baseline, there were 1223 men and 1362 women, with a mean age of 43 years, who were free of preexisting kidney disease. After a mean follow-up of 18.5 years, 244 participants (9.4%) had developed kidney disease. In multivariable models, baseline age (odds ratio [OR], 2.36 per 10-year increment; 95% confidence interval [CI], 2.00-2.78), GFR ( or =120 mL/min per 1.73 m2), a mildly reduced GFR ( Conclusions Established cardiovascular disease risk factors are associated with the development of new-onset kidney disease. Patients with a mildly reduced GFR should be monitored for progression to kidney disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While dyslipidemia is a risk factor for progressive kidney disease (8,10,20,21)”
From Effects of Fibrates in Kidney Disease (2012) · cites this paper as [8]
Citations
Cites
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
Klahr, S., Levey, A. S., Beck, G. J., Caggiula, A. W., Hunsicker, L., Kusek, J. W., & Striker, G. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403313301301 · Cited by 2,328
Flagged first, then by citations
Cited by
Sorted by citations
Items 601–700 of 1,003
Diamantidis, C. J., Bosworth, H. B., Oakes, M. M., Davenport, C. A., Pendergast, J., Patel, S., Moaddeb, J., Barnhart, H. X., Merrill, P. D., Baloch, K. N., et al. (2018) · Contemporary Clinical Trials · doi:10.1016/j.cct.2018.04.003 · Cited by 23
Dietary Guideline Adherence Index and Kidney Measures in the Framingham Heart Study
Ma, J., Jacques, P. F., Hwang, S., Troy, L. M., McKeown, N. M., Chu, A. Y., & Fox, C. S. (2016) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2016.04.015 · Cited by 19
Self-citationRetrospective Analysis of Vancomycin Nephrotoxicity in Elderly Chinese Patients
Liu, Y., Yin, Y., Liu, X.-Z., Yao, H., Li, L.-X., Chen, J.-H., Chen, T., Lu, X.-T., Bu, S., & Zhang, J. (2015) · Pharmacology · doi:10.1159/000381783 · Cited by 18
Fu, C.-P., Sheu, W., Lee, I., Lee, W.-J., Wang, J.-S., Liang, K.-W., Lee, W.-L., & Lin, S.-Y. (2015) · Clinical Chemistry and Laboratory Medicine · doi:10.1515/cclm-2014-0468 · Cited by 18
Gupta, A., Braunwald, E., Mcnulty, S., Felker, G., Gilbert, E., Alharethi, R., Lee, K. L., Anstrom, K., Redfield, M., Goldsmith, S., et al. (2012) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2012.09.005 · Cited by 18
el Barzouhi, A., Elias-Smale, S., Dehghan, A., Vliegenthart-Proença, R., Oudkerk, M., Hofman, A., & Witteman, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016738 · Cited by 18
“3 mmol/L) [26].”
López-Suárez, A., Beltrán-Robles, M., Elvira-González, J., Fernández-Palacín, F., Bascuñana-Quirell, A., Benítez-Del-Castillo, J., & Gómez-Fernández, P. (2010) · Medicina clínica (Ed. impresa) · doi:10.1016/j.medcli.2009.07.055 · Cited by 18
Pathophysiology of Obesity—Induced Hypertension and Target Organ Damage
Hall, J. E., da Silva, A. A., Brandon, E. L., Stec, D. E., Ying, Z., & Jones, D. W. (2007) · Elsevier eBooks · doi:10.1016/b978-0-323-03961-1.50041-6 · Cited by 18
Cho, H.-K., Han, J., Choi, J. A., Chae, J., & Kim, R. (2021) · Investigative Ophthalmology and Visual Science · doi:10.1167/iovs.62.6.27 · Cited by 17
Kuo, Y.-T., Wang, Y.-Y., Lin, S.-Y., & Chang, W.-D. (2018) · Clinica chimica acta; international journal of clinical chemistry · doi:10.1016/j.cca.2018.07.025 · Cited by 17
Janki, S., Dols, L. F. C., Timman, R., Mulder, E. E. A. P., Dooper, I. M. M., van de Wetering, J., & IJzermans, J. N. M. (2016) · Transplant International · doi:10.1111/tri.12872 · Cited by 19
Managing End-Stage Renal Disease in the Elderly: State-Of-The-Art, Challenges and Opportunities
Somma, C., Trillini, M., Kasa, M., & Gentile, G. (2013) · Aging Health · doi:10.2217/ahe.13.52 · Cited by 16
“It is currently believed that agerelated decline in GFR is a complex process due to progressive changes in the vascular tree, which involve oxi dative stress, metalloprotease activity, telomere shortening, Ang II, via Ang II type 1 receptor stimulation, and finally reactive oxygen spe cies [22,40–44].”
BackgroundRosa, P. D., Muscogiuri, G., & Sarno, G. (2013) · doi:10.5402/2013/301025 · Cited by 17
Malkina, A., Katz, R., Shlipak, M., H., J., de Boer, I. D., Sarnak, M., Allison, M., Kramer, H., Lin, J., Siscovick, D., et al. (2013) · Open Journal of Endocrine and Metabolic Diseases · doi:10.4236/ojemd.2013.32016 · Cited by 17
“For example, while high BMI has been associated with incident CKD in some studies [6–8], other reports have been null [31], or are confounded by cardiovascular disease risk factors [9,10].”
InfluentialKawai, T., Kamide, K., Onishi, M., Hongyo, K., Yamamoto-Hanasaki, H., Oguro, R., Maekawa, Y., Yamamoto, K., Takeya, Y., Sugimoto, K., et al. (2012) · Clinical and Experimental Nephrology · doi:10.1007/s10157-012-0627-1 · Cited by 17
Ohnishi, M., Kato, S., & Razzaque, M. S. (2011) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2011.10.076 · Cited by 17
“In a 20 year follow-up study, a single unit increase of body mass index was shown to be responsible for a 20% increase in kidney disease [33].”
BackgroundO’Seaghdha, C. M., Hwang, S., Bhavsar, N. A., Köttgen, A., Coresh, J., Astor, B. C., & Fox, C. S. (2011) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.11.022 · Cited by 19
“These covariates were selected because they were predictive of incident CKD in previous studies.(32) In ARIC, selection was stratified into 16 groups defined by race, sex, and 5-year age windows (ie, frequency matching rather than individual matching), and 10 of the 16 groups had equal numbers of cases and controls.”
MethodInfluentialSelf-citationSahin, I., Yildirim, B., Cetin, I., Etikan, I., Ozturk, B., Ozyurt, H., & Tasliyurt, T. (2009) · Renal Failure · doi:10.3109/08860220903219265 · Cited by 17
“36 times with every 10 years of age in the Framingham study.([25]) Similarly, we found an increase of CKD prevalence with age in our study.”
The Effect of Cholesterol Reduction With Cholestyramine on Renal Function
Kshirsagar, A. V., Shoham, D. A., Bang, H., Hogan, S. L., Simpson, R. J., & Colindres, R. E. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.08.012 · Cited by 13
Renal changes in the early stages of diet-induced obesity in ovariectomized rats.
Amaral, L. B., Silva, J., Trindade, T. M., Ribas, W. B. D., Macêdo, C. L., Coimbra, T., Belo, N. O., Magalhães, A., & Soares, T. J. (2014) · Physiological Research · doi:10.33549/physiolres.932619 · Cited by 17
“Therefore, metabolic syndrome may induce renal damage before the appearance of hypertension and diabetes (Fox et al. 2004, Hsu et al. 2006).”
BackgroundJairoun, A., Al-Hemyari, S., Shahwan, M., Zyoud, S., & El-Dahiyat, F. (2024) · Scientific Reports · doi:10.1038/s41598-024-56765-0 · Cited by 16
Ocular manifestations in renal diseases
Goyal, J. L., Gupta, A., & Gandhi, P. (2023) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_3234_22 · Cited by 22
“[21] Common risk factors between CKD and eye include old age,[22,23] smoking,[24] hypertension,[24‐26] diabetes mellitus,[27,28] obesity, and hyperlipidemia.”
BackgroundCen, J., Han, Y. Y., Liu, Y., & Hu, H. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.916704 · Cited by 24
“The rising Abbreviations: NAFLD, Non-alcoholic fatty liver disease; eGFR, Evaluated glomerular filtration rate; FPG, Fasting plasma glucose; SBP, systolic blood pressure; NASH, non-alcoholic steatohepatitis; BMI, Body mass index; Scr, Serum creatinine; DBP, diastolic blood pressure; ALT, Alanine aminotransferase; UA,…”
BackgroundChen, I.-J., Hsu, L., Lu, M.-C., Chen, Y.-J., Tsou, M.-T., & Chen, J.-Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.737586 · Cited by 16
Melsom, T., Norvik, J. V., Enoksen, I. T., Stefansson, V. T. N., Rismo, R., Jenssen, T. G., Solbu, M. D., & Eriksen, B. O. (2021) · Kidney International Reports · doi:10.1016/j.ekir.2021.05.007 · Cited by 19
Blood Pressure and Chronic Kidney Disease Stratified by Gender and the Use of Antihypertensive Drugs
Satoh, M., Hirose, T., Nakayama, S., Murakami, T., Takabatake, K., Asayama, K., Imai, Y., Ohkubo, T., Mori, T., & Metoki, H. (2020) · Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease · doi:10.1161/jaha.119.015592 · Cited by 16
Momeni, A., Mardani, S., Kabiri, M., & Amiri, M. (2017) · Advanced Biomedical Research · doi:10.4103/2277-9175.213666 · Cited by 16
“[1,2] Aging, diabetes mellitus, hypertension, and cardiovascular disease are some common and important risk factors for CKD.[3,4] Since severe renal failure is incompatible with life, renal replacement therapy with hemodialysis, peritoneal dialysis, or kidney transplantation should be carried out at this stage.”
BackgroundHu, W., Wu, X., Ni, Y., Hao, H., Yu, W., & Zhou, H. (2017) · BMC Nephrology · doi:10.1186/s12882-017-0597-3 · Cited by 16
“Furthermore, even mild renal insufficiency increases the risk of cardiovascular events [5, 6] and also serves as a predictor of the progression of kidney disease [7].”
BackgroundHirata, A., Okamura, T., Sugiyama, D., Kuwabara, K., Kadota, A., Fujiyoshi, A., Miura, K., Okuda, N., Ohkubo, T., Okayama, A., et al. (2017) · European Journal of Preventive Cardiology · doi:10.1177/2047487316679904 · Cited by 16
Chen, J.-Y., Tsai, Y.-W., Chen, S.-Y., Ho, C.-I., Weng, Y.-M., Hsiao, C.-T., & Li, W.-C. (2015) · Clinical Nutrition · doi:10.1016/j.clnu.2014.10.001 · Cited by 16
Bariatric Surgery in a Patient on Peritoneal Dialysis
Imam, T., Wang, J., & Khayat, F. S. (2013) · Peritoneal Dialysis International · doi:10.3747/pdi.2012.00272 · Cited by 16
Foster, M., Yang, Q., Hwang, S.-J., Hoffmann, U., & Fox, C. (2011) · BMC Medical Genetics · doi:10.1186/1471-2350-12-148 · Cited by 16
“Foster MC, Hwang SJ, Larson MG, Lichtman JH, Parikh NI, Vasan RS, Levy D, Fox CS: Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study.”
BackgroundInfluentialSelf-citationEstimating glomerular filtration rate in a population-based study
Shankar, A., Lee, K. E., Klein, B., Muntner, P., Brazy, P., Cruickshanks, K., Nieto, F., Danforth, L. G., Schubert, C., Tsai, M., et al. (2010) · Vascular Health and Risk Management · doi:10.2147/vhrm.s11269 · Cited by 16
“In the Framingham Heart Study, Fox et al 6 noted that even after calibration, the use of an MDRD eGFR cutoff of , 60 mL/min per 1.73 m 2 overestimated CKD in women; a different ad hoc cutoff defined as eGFR at or below the sex-specific fifth percentile was used to define CKD in that study.”
InfluentialSurdacki, A., Marewicz, E., Wieczorek‐Surdacka, E., Rakowski, T., Szastak, G., Pryjma, J. R., Dudek, D., & Dubiel, J. S. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp439 · Cited by 14
Halbesma, N., Jansen, D., Stolk, R., de Jong, P. D., & Gansevoort, R. (2010) · Nephrology, Dialysis and Transplantation · doi:10.1093/ndt/gfp729 · Cited by 16
Kersting, S., & Verdonck, L. (2008) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2008.08.015 · Cited by 16
Phosphorus Comes of Age as a Cardiovascular Risk Factor
Foley, R. N. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.9.873 · Cited by 18
Higher NAFLD fibrosis score is associated with impaired eGFR.
Hsieh, M., Wu, K.-T., Chen, Y.-Y., Yang, J.-F., Lin, W.-Y., Chang, N., Lin, C.-Y., Huang, C.-K., Wang, C.-L., Chuang, H., et al. (2019) · Journal of the Formosan Medical Association = Taiwan yi zhi · doi:10.1016/j.jfma.2019.07.007 · Cited by 16
Chronic Kidney Disease: Definition, Epidemiology, Cost, and Outcomes
Shafi, T., & Coresh, J. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4377-0987-2.00001-7 · Cited by 16
Guías de práctica clínica sobre prevención de la enfermedad cardiovascular: versión resumida
y otras, C. G. D. T. C. D. L. S. E. D. C., & Clínica, S. S. P. D. L. E. C. E. L. P. (2008) · Revista Española de Cardiología · doi:10.1157/13114961 · Cited by 19
Adjei, D. N., Stronks, K., Adu, D., Beune, E., Meeks, K. A. C., Smeeth, L. L., Addo, J., Owusu‐Dabo, E., Klipstein‐Grobusch, K., Mockenhaupt, F. P., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-027931 · Cited by 15
Bariatric Surgery Reduces Elevated Urinary Mitochondrial DNA Copy Number in Patients With Obesity
Lee, H., Oh, S., Yang, W., Park, R., Kim, H., Jeon, J. S., Noh, H., Han, D. C., Cho, K. W., Kim, Y. J., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01935 · Cited by 16
Zheng, X., Chen, Q.-B., & Chen, L. (2019) · Renal Failure · doi:10.1080/0886022x.2019.1685545 · Cited by 15
Bjornstad, P., Lovshin, J., Lytvyn, Y., Boulet, G., Lovblom, L., Alhuzaim, O. N., Farooqi, M. A., Lai, V., Tse, J., Cham, L., et al. (2018) · Diabetes Care · doi:10.2337/dc17-2475 · Cited by 15
Kim, E. J., Ahn, J. Y., Kim, Y. J., Wie, S., Park, D. W., Song, J. Y., Choi, H. J., Chang, H., Choi, B. Y., Choi, Y., et al. (2017) · Infection and Chemotherapy · doi:10.3947/ic.2017.49.3.194 · Cited by 17
“In addition, a traditional CKD risk factor, BMI, was not significant in this study [38].”
BackgroundOguri, M., Fujimaki, T., Horibe, H., Kato, K., Matsui, K., Takeuchi, I., & Yamada, Y. (2016) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2016.08.008 · Cited by 20
Prudente, S., Paola, R. D., Copetti, M., Lucchesi, D., Lamacchia, O., Pezzilli, S., Mercuri, L., Alberico, F., Giusti, L., Garofolo, M., et al. (2016) · Nephrology, Dialysis and Transplantation · doi:10.1093/ndt/gfw262 · Cited by 15
Stafylas, P. C., Kourlaba, G., Hatzikou, M., Georgiopoulos, D., Sarafidis, P. A., & Maniadakis, N. (2015) · Cost Effectiveness and Resource Allocation · doi:10.1186/s12962-015-0036-x · Cited by 19
Metabolic syndrome and chronic kidney disease in a rural Chinese population.
Jiang, L.-P., Liang, Y. B., Qiu, B., Wang, F.-H., Duan, X., Yang, X., Yang, J.-G., Huang, W., & Wang, N.-L. (2011) · Clinica chimica acta; international journal of clinical chemistry · doi:10.1016/j.cca.2011.07.014 · Cited by 15
Relationship between estimated glomerular filtration rate (eGFR) and metabolic syndrome in Japanese.
Miyatake, N., Shikata, K., Makino, H., & Numata, T. (2010) · Acta Medica Okayama · doi:10.18926/amo/40013 · Cited by 15
“In some studies, CKD is closely related to body composition parameters and metabolic syndrome [8-18].”
BackgroundAekplakorn, W., Srivanichakorn, S., & Sangwatanaroj, S. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.12.020 · Cited by 14
“However, the association between albuminuria and dyslipidemia especially triglyceride were less consistent [11–17].”
Use of Renal Function Measurements for Assessing Fracture Risk in Postmenopausal Women
McCarthy, J. T., Rule, A., Achenbach, S. J., Bergstralh, E., Khosla, S., & Melton, L. (2008) · Mayo Clinic proceedings · doi:10.4065/83.11.1231 · Cited by 15
Risk Factors and Chronic Kidney Disease
Taal, M. W. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-6193-9.10021-1 · Cited by 13
Functional and structural renal changes in the early stages of obesity.
Thakur, V., Morse, S., & Reisin, E. (2006) · Contributions to Nephrology · doi:10.1159/000095325 · Cited by 15
Oh, D., Lee, S., Yang, E., Choi, H.-Y., Park, H., & Jhee, J. (2023) · Kidney Research and Clinical Practice · doi:10.23876/j.krcp.23.043 · Cited by 14
“Especially, high TG, low HDL-C level, and high TC/HDL-C ratio were significantly associated with an increased risk of developing decreased kidney function [10,11,19].”
Chen, J.-H., Tsai, C.-C., Liu, Y.-H., Wu, P.-Y., Huang, J.-C., Chung, T.-L., Su, H.-M., & Chen, S.-C. (2022) · Nutrients · doi:10.3390/nu14183832 · Cited by 14
Nguyen, M., Walia, A., Saidian, A., Puri, D., Meagher, M., Hakimi, K., Tanaka, H., Patil, D., Yasuda, Y., Saito, K., et al. (2022) · BJU International · doi:10.1111/bju.15861 · Cited by 14
Shen, F., Chiu, Y.-W., Kuo, M.-C., Lin, M.-Y., Lee, J.-J., Hwang, S.-J., Chang, J.-M., Hung, C.-C., & Chen, H. C. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11121355 · Cited by 14
“High body mass index (BMI) was related to the development of kidney disease in general population [1].”
BackgroundYang, C.-Y., Liu, J.-S., Tseng, W.-C., Tsai, M.-T., Lin, M.-H., Kao, Z.-K., Lin, Y.-P., Hsu, C.-C., & Tarng, D. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004588 · Cited by 14
Evidence for a Causal Role of the SH2B3 -β 2 M Axis in Blood Pressure Regulation
Keefe, J. A., Hwang, S., Huan, T., Mendelson, M., Yao, C., Courchesne, P. L., Saleh, M. A., Madhur, M. S., & Levy, D. A. (2019) · Hypertension · doi:10.1161/hypertensionaha.118.12094 · Cited by 21
de Oliveira, J. D., Askari, M., da Silva, G. D., de Freitas, R. A., & Vasconcelos, J. E. (2019) · Kidney International Reports · doi:10.1016/j.ekir.2019.01.008 · Cited by 14
Ramezankhani, A., Azizi, F., Ghanbarian, A., Parizadeh, D., & Hadaegh, F. (2017) · Obesity Research and Clinical Practice · doi:10.1016/j.orcp.2016.11.003 · Cited by 14
Kramer, H., Colangelo, L., Lewis, C., Jacobs, D., Pletcher, M., Bibbins-Domingo, K., Chang, A. R., Siscovick, D., Shlipak, M., Peralta, C., et al. (2017) · American Journal of Hypertension · doi:10.1093/ajh/hpx012 · Cited by 14
Franceschini, N., Deng, Y., Flessner, M., Eckfeldt, J., Kramer, H., Lash, J., Lee, D. J., Melamed, M., Moncrieft, A., Ricardo, A., et al. (2016) · Nephrology, Dialysis and Transplantation · doi:10.1093/ndt/gfw210 · Cited by 14
Residual lifetime risk of chronic kidney disease
McMahon, G., Hwang, S.-J., & Fox, C. (2016) · Nephrology, Dialysis and Transplantation · doi:10.1093/ndt/gfw253 · Cited by 14
“In addition, although hypertension, diabetes and obesity are known key risk factors for the development of CKD [12], the effect of risk factor burden on modifying CKD risk is not well known.”
BackgroundSelf-citationEvaluation and Management of the Older Adult with Chronic Kidney Disease
Rivas, K. M., Hames, E., & Masri, H. (2014) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2014.08.006 · Cited by 15
Ahn, S., Ryu, J., Baek, S. H., Kim, S., Na, K., Kim, K. W., Chae, D., & Chin, H.-J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084467 · Cited by 14
“In community-based cohort studies [19,21], baseline renal function was found to be an independent factor for renal dysfunction or incident CKD.”
BackgroundMetabolic syndrome component combinations and chronic kidney disease: the severance cohort study.
Cho, J., Lee, S.-J., Reid, E., & Sun, H.-J. (2013) · Maturitas · doi:10.1016/j.maturitas.2013.02.006 · Cited by 14
Inverse association between body mass index and chronic kidney disease in older diabetic adults.
Kao, Y.-M., & Chen, J.-D. (2013) · Annals of Epidemiology · doi:10.1016/j.annepidem.2013.03.005 · Cited by 14
Longitudinal trends and influence of BMI mismatch in living kidney donors and their recipients
Lin, J., McGovern, M. E., Brunelli, S., Gaccione, P., Malek, S., Tullius, S., Chandraker, A., & Milford, E. (2011) · International Urology and Nephrology · doi:10.1007/s11255-011-9921-1 · Cited by 14
“progression and end-stage renal disease (ESRD) either directly as an independent risk factor [2, 3] or mediated by the development of diabetes mellitus [4].”
Isbel, N. M. (2010) · Nephrology · doi:10.1111/j.1440-1797.2009.01221.x · Cited by 17
Chronic Kidney Disease after Nonmyeloablative Stem Cell Transplantation in Adults
Kersting, S., & Verdonck, L. F. (2008) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2007.12.495 · Cited by 15
Yang, L.-S., Huang, S.-Y., Sheng, S.-Y., Liu, X.-B., Ma, S.-L., & Zhu, F. (2025) · Obesity Facts · doi:10.1159/000545356 · Cited by 13
“Previous research demonstrated that a higher BMI is associated with an elevated risk of CKD in individuals without prior kidney disease, following an average follow-up period of 18.5 years [7].”
InfluentialAtaka, E., Matsukuma, Y., Ueki, K., Tsuchimoto, A., Okabe, Y., Masutani, K., Nakamura, M., Nakano, T., & Kitazono, T. (2023) · Nephrology, Dialysis and Transplantation · doi:10.1093/ndt/gfad124 · Cited by 13
Xuan, Y., Shen, Y., Wang, S., Gao, P., Gu, X., Tang, D., Wang, X., Zhu, F., Lu, L., & Chen, L. (2022) · Journal of Clinical Hypertension · doi:10.1111/jch.14424 · Cited by 13
Hukportie, D. N., Li, F.-R., Zhou, R., Zou, M., Wu, X.-X., & Wu, X.-B. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.719666 · Cited by 13
Vascular Calcification as a Novel Risk Factor for Kidney Function Deterioration in the Nonelderly
Park, S., Cho, N.-J., Heo, N., Rhee, E., Gil, H.-U., & Lee, E. Y. (2021) · Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease · doi:10.1161/jaha.120.019300 · Cited by 13
Kong, J., Kim, J. S., Kang, M. H., Hwang, H., Won, C., & Jeong, K. (2020) · BMC Geriatrics · doi:10.1186/s12877-020-01862-8 · Cited by 13
Oliveira, I., Mintem, G., Oliveira, P. D., Freitas, D. F., Brum, C., Wehrmeister, F., Gigante, D., Horta, B., & Menezes, A. (2020) · NMCD. Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.04.016 · Cited by 13
Ma, J., Wan, X., & Wu, B. (2020) · Journal of Diabetes Research · doi:10.1155/2020/7410797 · Cited by 13
Twig, G., Vivante, A., Bader, T., Derazne, E., Tsur, A. M., Levi, M., Goldberger, N., Leiba, A., & Kark, J. D. (2018) · Obesity · doi:10.1002/oby.22144 · Cited by 14
Urogenital complications of obesity.
Morandi, A., & Maffeis, C. (2013) · Best practice & research. Clinical endocrinology & metabolism · doi:10.1016/j.beem.2013.04.002 · Cited by 13
Tocotrienols as possible treatments for obesity
Tan, B., Watson, R., & Preedy, V. (2012) · doi:10.1201/b12502 · Cited by 13
Guidone, C., Gniuli, D., Castagneto-Gissey, L., Leccesi, L., Arrighi, E., Iaconelli, A., & Mingrone, G. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2011.10.007 · Cited by 13
Glomerulonephritis and managing the risks of chronic renal disease.
Singh, G. (2009) · The Pediatric clinics of North America · doi:10.1016/j.pcl.2009.09.014 · Cited by 13
Renal function predicts cardiovascular outcomes in southern Italian postmenopausal women
Perticone, F., Sciacqua, A., Maio, R., Perticone, M., Laino, I., Bruni, R., Cello, S. D., Leone, G. G., Greco, L., Andreozzi, F., et al. (2009) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e32832b8d87 · Cited by 14
Sun, Y. S., Wang, C., Yang, W., Wang, Y., Zhang, X., Ma, Z., Song, J., Lin, P., Liang, K., Ma, A., et al. (2014) · International Urology and Nephrology · doi:10.1007/s11255-014-0880-1 · Cited by 11
Bae, E., Oh, T. R., Suh, S.-H.-O., Yang, E., Choi, H.-S., Kim, C., Ma, S., Kim, B., Han, K., & Kim, S. (2021) · Nutrients · doi:10.3390/nu14010154 · Cited by 12
“Two large epidemiologic studies in the United States reported a positive association between BMI and ESRD, and these studies analyzed a broad spectrum of BMI among a large, diverse sample of participants with long-term follow-up for ESRD [4,5].”
BackgroundRyu, H., Hong, Y., Kang, E., Kang, M., Kim, J., Oh, Y., Yang, S., Yang, Y.-J., Park, S.-K., Chung, W., et al. (2021) · Journal of renal nutrition · doi:10.1053/j.jrn.2021.01.026 · Cited by 12
Hydes, T. J., Buchanan, R., Kennedy, O., Fraser, S., Parkes, J., & Roderick, P. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-040970 · Cited by 12
Zhang, X., Wang, B.-Y., Yang, J., Wang, J., Yu, Y., Jiang, C.-F., Xie, L., Song, Y., Zhong, B., Li, Y., et al. (2019) · American Journal of Hypertension · doi:10.1093/ajh/hpz001 · Cited by 12
Zhang, L., Li, R., He, J., Yang, Q., Wu, Y., Huang, J., & Wu, B. (2017) · Methods · doi:10.1016/j.ymeth.2017.05.023 · Cited by 17
“In fact, diabetic kidney disease (DKD) is one of the most important microvascular complications of patients with diabetes mellitus (DM) [4].”
BackgroundSurana, S. P., Kumar, N., Vasudeva, A., Shaikh, G., Jhaveri, K., Shah, H., Malieckal, D. A., Fogel, J., Sidhu, G. S., & Rubinstein, S. (2017) · BMC Nephrology · doi:10.1186/s12882-017-0443-7 · Cited by 12
“Over the past two decades, there has been a 10–20% increase in incidence and prevalence of CKD stages 3–5 [3, 4].”
BackgroundMłodawska, E., Tomaszuk−Kazberuk, A., Łopatowska, P., Waszkiewicz, E., Bachórzewska-Gajewska, H., Małyszko, J., Michniewicz, E., Dobrzycki, S., & Musial, W. J. (2016) · Cardiorenal Medicine · doi:10.1159/000448225 · Cited by 11
Yu, S.-S., Yang, H.-M., Guo, X.-F., Zheng, L.-Q., & Sun, Y.-X. (2016) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph13060540 · Cited by 12
“As for dyslipidemia, there was growing evidence that confirmed that lipid metabolic abnormalities contributed to the progression of renal deficiency [28,29].”
BackgroundKang, Y.-U., Bae, E., Ma, S., & Kim, S. (2016) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2014.243 · Cited by 12
“It is known that hypertension and diabetes are risk factors for new-onset kidney disease [28,31].”
BackgroundThomas, I., Ratigan, A., Rifkin, D., H., J., Criqui, M., Budoff, M., & Allison, M. (2015) · Journal of the American Society of Hypertension : JASH · doi:10.1016/j.jash.2015.12.003 · Cited by 12
Disease Severity and Staging of Obesity: a Rational Approach to Patient Selection
Whyte, M., Velusamy, S., & Aylwin, S. J. B. (2014) · Current Atherosclerosis Reports · doi:10.1007/s11883-014-0456-7 · Cited by 16
Is Alcohol Drinking Associated with Renal Impairment in the General Population of South Korea?
Kim, H.-N., Kim, S.-H., & Song, S.-W. (2014) · Kidney & Blood Pressure Research · doi:10.1159/000355775 · Cited by 12
Chen, C., Hsu, T.-W., Mao, S. J. T., Chang, S.-C., Yang, P., Lee, Y.-C., & Yang, K. (2013) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2012.719051 · Cited by 13
“To date, several risk factors have been identifi ed for the development and progression of chronic kidney disease (CKD), such as ageing process, hypertension, diabetes, high body mass index and smoking (1).”
Background
Metadata
- Authors
- Fox, C. S.
- Affiliations
- Framingham Heart Study (US)
- Corresponding author
- Fox, Caroline S.
- ORCID
- Fox, Caroline S.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2004-02-18
- Volume
- 291
- Issue
- 7
- Pages
- 844
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W1992283514
- Cited by
- 1,241
- References
- 0
- Citations by year
- 2026: 21 · 2025: 28 · 2024: 50 · 2023: 37 · 2022: 53 · 2021: 62 · 2020: 62 · 2019: 47 · 2018: 49 · 2017: 59 · 2016: 81 · 2015: 49 · 2014: 79 · 2013: 83 · 2012: 68
- FWCI
- 28.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (n01hc25195-41-0-1)
- National Heart, Lung, and Blood Institute (N01‐HC25195)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Keywords
- chronic kidney disease, risk factors, glomerular filtration rate, diabetes mellitus, smoking, body mass index, age, MDRD equation, cardiovascular disease, end-stage renal disease, community-based cohort, risk prediction model, renal function decline, hyperlipidemia, antihypertensive drugs, antihypertensive medication adherence
- MeSH terms
- Adult, Aged, Cardiovascular Diseases, Female, Glomerular Filtration Rate, Humans, Kidney Diseases, Longitudinal Studies, Male, Middle Aged, Risk Factors, Logistic Models
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review